These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 4196796)

  • 41. [Vaccine prophylaxis and vaccine therapy of typhoid and carrier states. II. Chronic carriers].
    Busilă VT; Vasilescu I; Vâlceanu M; Fitărău A; Pintea L
    Microbiol Parazitol Epidemiol (Bucur); 1970; 15(5):399-406. PubMed ID: 5494966
    [No Abstract]   [Full Text] [Related]  

  • 42. Typhoid and paratyphoid immunization.
    Walker JH
    Practitioner; 1971 Apr; 206(234):478-82. PubMed ID: 4995968
    [No Abstract]   [Full Text] [Related]  

  • 43. [Characteristics of Vi-antibody formation in typhoid fever and chronic typhoid fever bacterial carriers].
    Karmanov MI
    Sov Med; 1973 May; 36(5):149-50. PubMed ID: 4768336
    [No Abstract]   [Full Text] [Related]  

  • 44. [Search for copro-agglutinins in the course of oral TAB vaccination].
    Freni S; Ingiulla M
    Boll Soc Ital Biol Sper; 1968 Dec; 44(23):2093-4. PubMed ID: 4981154
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinico-immunological mechanisms in typhoid and formation of bacteria carrier state].
    Bunin KV; Bunin MV
    Klin Med (Mosk); 1975 Feb; 53(2):3-10. PubMed ID: 1186056
    [No Abstract]   [Full Text] [Related]  

  • 46. [Animal experiments on antibody formation following thymectomy in adult rabbits].
    Hempel HC; Grimm J; Schwarz ER; Hofmann K; Korn D
    Dtsch Gesundheitsw; 1969 Jul; 24(28):1304-7. PubMed ID: 4987620
    [No Abstract]   [Full Text] [Related]  

  • 47. [Appearance of anti-gamma globulin factors after administration of vaccines].
    Masala C; Pala AM; De Philippis CV
    Folia Allergol (Roma); 1967; 14(6):602-6. PubMed ID: 4171232
    [No Abstract]   [Full Text] [Related]  

  • 48. Investigation of the role of Vi antibodies and antibodies of IgA type in the low specific bactericidal activity of the serum in typhoid carriers.
    Karolcek J; Draskovicová M; Ciznár I
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):247-51. PubMed ID: 1179883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Size of the immunizing dose and postvaccination immunity to typhoid and paratyphoid B from the results of controlled field trials.
    Hejfec LB
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(2):173-82. PubMed ID: 4996607
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunogenicity of typhoid and paratyphoid B components of divaccine when used orally (an experimental study)].
    Ianisker GIa; Faĭn VI; Meshalova AN
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):73-7. PubMed ID: 4980673
    [No Abstract]   [Full Text] [Related]  

  • 51. Typhoid vaccination--yesterday and today.
    Gröschel D
    Pa Med; 1967 Jul; 70(7):77-81. PubMed ID: 4962988
    [No Abstract]   [Full Text] [Related]  

  • 52. Problems of anti-typhoid immunity and protective vaccination against typhoid.
    Karolcek J
    Lek Pr; 1969; 7(1):3-153. PubMed ID: 4917329
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of immunizing properties of precipitated typhoid-paratyphoid vaccine in white mice].
    MAZUR W
    Med Dosw Mikrobiol; 1951; 3(2):185-97. PubMed ID: 14874890
    [No Abstract]   [Full Text] [Related]  

  • 54. [Problem of chronic typhoid and paratyphoid carriers from the sociological and epidemiologic viewpoint].
    Fiedler K
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1230-4. PubMed ID: 4994103
    [No Abstract]   [Full Text] [Related]  

  • 55. [Is the Widal reaction for typhoid and paratyphoid influenced by the oral intake of larger amounts of killed Salmonella?].
    Finger H; Seeliger H; Schmidt H
    Dtsch Med Wochenschr; 1967 May; 92(19):887-90. PubMed ID: 4960680
    [No Abstract]   [Full Text] [Related]  

  • 56. Typhoid and paratyphoid fever - prevention in travellers.
    Mayer CA; Neilson AA
    Aust Fam Physician; 2010 Nov; 39(11):847-51. PubMed ID: 21301658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical-epidemiological parallels in patients suffering from typhoid and paratyphoid fever treated with levomycetin in combination with vaccine].
    Musabaev IK; Nevskiĭ MV; Ambartsumov SM; Mikhaĭlovskaia OG; Kotiuminskaia NA; David'ian AO
    Sov Med; 1966 Jun; 29(6):64-9. PubMed ID: 4965445
    [No Abstract]   [Full Text] [Related]  

  • 58. [Situation of chronic carriers of typhus and paratyphus].
    Fiedler K; Miehlke G; Klein B
    Z Gesamte Hyg; 1976 Mar; 22(3):223-7. PubMed ID: 823721
    [No Abstract]   [Full Text] [Related]  

  • 59. Antibody and agglutinin response to TAB vaccination.
    HU HY; TSENG CS; HSU CN; YING KS
    Chin Med J; 1960 Jun; 80():554-61. PubMed ID: 14403630
    [No Abstract]   [Full Text] [Related]  

  • 60. [Search for O-agglutinins by passive hemagglutination in the serologic diagnosis of salmonella infections].
    Rykner G
    Pathol Biol (Paris); 1972 Apr; 20(7):377-82. PubMed ID: 4625176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.